GPT and metabolic dysfunction-associated steatotic liver disease: Noninvasive biomarkers such as alanine aminotransferase (ALT) have been used to detect NAFLD; however, studies found that normal levels of ALTs are found in NAFLD patients as well (Sumida et al., 2014).